Literature DB >> 16699322

Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.

Howard Colman1, Caterina Giannini, Li Huang, Javier Gonzalez, Kenneth Hess, Janet Bruner, Gregory Fuller, Lauren Langford, Christopher Pelloski, Joann Aaron, Peter Burger, Ken Aldape.   

Abstract

Distinguishing between grade II and grade III diffuse astrocytomas is important both for prognosis and for treatment decision-making. However, current methods for distinguishing between grades based on proliferative potential are suboptimal, making identification of clear cutoffs difficult. In this study, we compared the results from immunohistochemical staining for phospho-histone H3 (pHH3), a specific marker of cells undergoing mitosis, with standard mitotic counts (number of mitoses/10 high-power fields) and MIB-1 labeling index values for assessing proliferative activity. We tested the relationship between pHH3 staining and tumor grade and prognosis in a retrospective series of grade II and III infiltrating astrocytomas from a single institution. The pHH3 index (per 1000 cells), MIB-1 index (per 1000 cells), and number of mitoses per 10 high-power fields were determined for each of 103 cases of grade II and III diffuse astrocytomas from patients with clinical follow-up. pHH3 staining was found to be a simple and reliable method for identifying mitotic figures, allowing a true mitotic index to be determined. The pHH3 mitotic index was significantly associated both with the standard mitotic count and with the MIB-1 index. Univariate analyses revealed that all 3 measurements of proliferation were significantly associated with survival. However, the pHH3 mitotic index accounted for a larger proportion of variability in survival than standard mitotic count or MIB-1/Ki-67 labeling index. After adjusting for age, extent of resection, and performance score, the pHH3 mitotic index remained an independent predictor of survival. Thus, pHH3 staining provides a simple and reliable method for quantifying proliferative potential and for the stratification of patients with diffuse astrocytomas into typical grade II and III groups. These results also suggest that pHH3 staining may be a useful method in other neoplasms in which accurate determination of proliferation potential is relevant to tumor grading or clinical treatment decision-making.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699322     DOI: 10.1097/01.pas.0000202048.28203.25

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  52 in total

1.  Global mitotic phosphorylation of C2H2 zinc finger protein linker peptides.

Authors:  Raed Rizkallah; Karen E Alexander; Myra M Hurt
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

2.  Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.

Authors:  Eleonora Duregon; Adele Cassenti; Alessandra Pittaro; Laura Ventura; Rebecca Senetta; Roberta Rudà; Paola Cassoni
Journal:  Neuro Oncol       Date:  2015-02-01       Impact factor: 12.300

3.  Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti-Vascular Endothelial Growth Factor Therapy-Induced Glioma Dissemination.

Authors:  Jean-Pierre Gagner; Yasmeen Sarfraz; Valerio Ortenzi; Fawaz M Alotaibi; Luis A Chiriboga; Awab T Tayyib; Garry J Douglas; Eric Chevalier; Barbara Romagnoli; Gérald Tuffin; Michel Schmitt; Guillaume Lemercier; Klaus Dembowsky; David Zagzag
Journal:  Am J Pathol       Date:  2017-07-20       Impact factor: 4.307

4.  Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma.

Authors:  Samuel A Henderson; Michael T Tetzlaff; Penvadee Pattanaprichakul; Patricia Fox; Carlos A Torres-Cabala; Roland L Bassett; Victor G Prieto; Hunter W Richards; Jonathan L Curry
Journal:  J Cutan Pathol       Date:  2014-10-28       Impact factor: 1.587

5.  Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors.

Authors:  Arnaud Uguen; Gwenaël Conq; Laurent Doucet; Matthieu Talagas; Sebastian Costa; Marc De Braekeleer; Pascale Marcorelles
Journal:  Virchows Arch       Date:  2015-04-01       Impact factor: 4.064

6.  Eyes absent 1 (Eya1) is a critical coordinator of epithelial, mesenchymal and vascular morphogenesis in the mammalian lung.

Authors:  Ahmed H K El-Hashash; Denise Al Alam; Gianluca Turcatel; Saverio Bellusci; David Warburton
Journal:  Dev Biol       Date:  2010-12-01       Impact factor: 3.582

7.  Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas--an assessment of 3 new variables in predicting clinical outcome.

Authors:  Linda R Margraf; Lynn Gargan; Yasmeen Butt; Nirupa Raghunathan; Daniel C Bowers
Journal:  Neuro Oncol       Date:  2011-06-08       Impact factor: 12.300

8.  Transglutaminase-1 regulates renal epithelial cell proliferation through activation of Stat-3.

Authors:  Zhu Zhang; Jingping Xing; Li Ma; Rujun Gong; Y Eugene Chin; Shougang Zhuang
Journal:  J Biol Chem       Date:  2008-12-02       Impact factor: 5.157

9.  Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males.

Authors:  Tao Sun; Nicole M Warrington; Jingqin Luo; Michael D Brooks; Sonika Dahiya; Steven C Snyder; Rajarshi Sengupta; Joshua B Rubin
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

10.  Low-grade gliomas in adults.

Authors:  Sandeep Mittal; Mark C Szlaczky; Geoffrey R Barger
Journal:  Curr Treat Options Neurol       Date:  2008-07       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.